Colgate-Palmolive Company (CL)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $80.28B
Last updated: Nov 17, 2026 at 4:40 PM ET
Colgate-Palmolive Company (CL) Statistics
Colgate-Palmolive Company (CL) has a market cap of $80.28B and an enterprise value of $86.47B. Its return on invested capital of 28.83% compares with a 13.02% median across 10 similar companies.
Total Valuation
Enterprise value is 7.71% above the market cap, as debt exceeds cash.
| Market Cap | $80.28B |
|---|---|
| Enterprise Value | $86.47B |
| Latest price (Nov 17, 2026) | $99.64 |
Key Dates
The next earnings report is expected on Jan 28, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Oct 20, 2026.
| Next Earnings Date | Jan 28, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 30, 2026 |
| Last Ex-Dividend Date | Oct 20, 2026 |
| Last Payment Date | Nov 13, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.7x and 275.0x. Its year-end P/E ranged from 20.0x to 28.0x from 2016 to 2025.
| P/E Ratio | 25.7x |
|---|---|
| Forward P/E | 24.7x |
| P/S Ratio | 3.7x |
| Forward P/S | 3.8x |
| P/B Ratio | 275.0x |
| P/FCF Ratio | 20.9x |
| P/OCF Ratio | 18.4x |
| PEG Ratio | 4.3 |
Enterprise Valuation
Counting debt and cash, the company is valued at 22.5x EBITDA and 22.5x free cash flow.
| EV / Earnings | 39.8x |
|---|---|
| EV / Sales | 4.1x |
| EV / EBITDA | 22.5x |
| EV / EBIT | 27.5x |
| EV / FCF | 22.5x |
Price Statistics
The stock is up 28.45% over 52 weeks and trades 9.31% above its 50-day average.
| Beta (1Y) | -0.09 |
|---|---|
| 52-Week Change | +28.45% |
| 1-Month Change | +7.29% |
| 3-Month Change | +10.27% |
| 6-Month Change | +11.32% |
| 5-Year Change | +25.07% |
| 10-Year Change | +33.53% |
| Total Return (1Y) | +31.17% |
| Total Return (3Y CAGR) | +11.32% |
| Total Return (5Y CAGR) | +7.48% |
| Return vs SPY (1Y) | +14.81% |
| Max Drawdown (1Y) | -16.96% |
| Max Drawdown (3Y) | -29.50% |
| Sharpe Ratio (1Y) | 1.00 |
| Correlation with SPY (1Y) | -0.05 |
| 50-Day Average | $91.15 |
| 200-Day Average | $89.76 |
| 52-Week Range | $74.18 to $101.81 |
| RSI (14 Days) | 62.8 |
| Average Volume (20 Days) | 5.29M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.96x current liabilities, and total debt is 26.79x shareholder equity.
| Current Ratio | 0.96x |
|---|---|
| Quick Ratio | 0.63x |
| Debt / Equity | 26.79x |
| Debt / EBITDA | 2.03x |
| Debt / FCF | 2.04x |
| Interest Coverage | 12.65x |
Returns and Efficiency
Return on invested capital is 28.83% over the last 12 months, against a 5-year average of 30.43%.
| Return on Equity (ROE) | 755.21% |
|---|---|
| Return on Assets (ROA) | 12.99% |
| Return on Invested Capital (ROIC) | 28.83% |
| Return on Capital Employed (ROCE) | 31.17% |
| ROA (5Y Average) | 15.17% |
| ROIC (5Y Average) | 30.43% |
| Asset Turnover | 1.24x |
| Inventory Turnover | 3.84x |
| Receivables Turnover | 11.02x |
| Cash Conversion Cycle | 36 days |
Taxes
Income tax took 26.72% of pretax income over the last 12 months.
| Income Tax (TTM) | $793.00M |
|---|---|
| Effective Tax Rate | 26.72% |
Scores
CL has an Altman Z-Score of 7.12, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 7.12 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $21.28B over the last 12 months is up 5.91% from the 12 months before.
| Revenue | $21.28B |
|---|---|
| Revenue Growth (YoY) | +5.91% |
| Gross Profit | $12.90B |
| Operating Income | $3.16B |
| Pretax Income | $2.97B |
| Net Income | $2.17B |
| EBITDA | $3.79B |
| EBIT | $3.15B |
| Reported EPS (TTM) | $3.88 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 1.72% of the $16.74B in total assets.
| Cash and Equivalents | $1.53B |
|---|---|
| Total Debt | $7.72B |
| Net Debt | $6.19B |
| Net Debt Per Share | $7.79 |
| Working Capital | -$282.00M |
| Shareholder Equity | $288.00M |
| Book Value Per Share | $0.36 |
| Tangible Book Value | -$4.26B |
| Total Assets | $16.74B |
| Total Liabilities | $16.10B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $577.00M of capital spending, operating cash flow left $3.79B of free cash flow.
| Operating Cash Flow | $4.37B |
|---|---|
| Capital Expenditures | $577.00M |
| Free Cash Flow | $3.79B |
| FCF Per Share | $4.75 |
| Depreciation and Amortization | $643.00M |
| Dividends Paid | $1.83B |
| Share Repurchases | $1.33B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 14.84%, against a 5-year average of 18.63%.
| Gross Margin | 60.61% |
|---|---|
| Operating Margin | 14.84% |
| Pretax Margin | 13.94% |
| Net Margin | 10.22% |
| EBITDA Margin | 17.82% |
| EBIT Margin | 14.80% |
| FCF Margin | 17.80% |
| Gross Margin (5Y Average) | 59.08% |
| Operating Margin (5Y Average) | 18.63% |
| Net Margin (5Y Average) | 12.65% |
Growth
Revenue grew 4.29% a year over 3 years, and EPS 7.50% a year.
| Revenue Growth (3Y CAGR) | +4.29% |
|---|---|
| Revenue Growth (5Y CAGR) | +4.35% |
| EPS Growth (3Y CAGR) | +7.50% |
| EPS Growth (5Y CAGR) | +3.88% |
| FCF Growth (3Y CAGR) | +25.01% |
| FCF Growth (5Y CAGR) | +1.89% |
| Operating Income Growth (3Y CAGR) | +4.55% |
| Book Value Per Share Growth (2Y CAGR) | -69.85% |
Dividends and Yields
CL pays out 77.12% of earnings as dividends.
| Dividend Per Share (Annual) | $2.12 |
|---|---|
| Dividend Yield | 2.13% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +3.46% |
| Dividend Growth (5Y CAGR) | +3.32% |
| Payout Ratio | 77.12% |
| FCF Payout Ratio | 48.32% |
| Earnings Yield | 3.89% |
| FCF Yield | 4.78% |
| Buyback Yield | 1.68% |
| Shareholder Yield | 3.99% |
Stock Splits
The last split was a 2-for-1 forward split on May 16, 2013.
| Last Split Date | May 16, 2013 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 11 similar companies, CL has the 4th highest P/E and the 3rd highest P/S.
P/E RatioPeer median 17.1x
P/S RatioPeer median 2.0x
ROICPeer median 13.02%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +2.14%
Dividend YieldPeer median 2.48%
| P/E Ratio | 25.7x vs 17.1x median |
|---|---|
| P/S Ratio | 3.7x vs 2.0x median |
| ROIC | 28.83% vs 13.02% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +5.91% vs +2.14% median |
| Dividend Yield | 2.13% vs 2.48% median |
Analyst Forecast
Consensus estimates put revenue growth at 3.63% and EPS growth at 5.41% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +3.63% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +5.41% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CL
What is CL's market cap?
Colgate-Palmolive Company has a market cap of $80.28B. Its enterprise value, which adds debt and subtracts cash, is $86.47B.
What is CL's P/E ratio?
Colgate-Palmolive Company has a trailing P/E ratio of 25.7x and a forward P/E of 24.7x.
How many shares of CL are outstanding?
Colgate-Palmolive Company has 794.92M shares outstanding. The count is down 1.38% from a year earlier.
Does CL pay a dividend?
Yes. Colgate-Palmolive Company pays $2.12 a share a year, a dividend yield of 2.13%.
How much debt does CL have?
Colgate-Palmolive Company has $7.72B of total debt and $1.53B of cash and equivalents, a net debt position of $6.19B.
CL pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors